Journal
CURRENT GENE THERAPY
Volume 15, Issue 6, Pages 541-549Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1566523215666150929111048
Keywords
Gene expression; Influenza; Flu infection; Plasmid DNA; Purification; Vaccines
Categories
Funding
- FCT grant [SFRH/BD/82196/2011]
- [PEst-C/SAU/UI0709/2014 COMPETE]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/82196/2011] Funding Source: FCT
Ask authors/readers for more resources
Current influenza vaccines have long been used to fight flu infectious; however, recent advances highlight the importance of produce new alternatives. Even though traditional influenza vaccines are safe and usually effective, they need to be uploaded every year to anticipate circulating flu viruses. This limitation together with the use of embryonated chicken eggs as the substrate for vaccine production, is time-consuming and could involve potential biohazards in growth of new virus strains. Plasmid DNA produced by prokaryote microorganisms and encoding foreign proteins had emerged as a promising therapeutic tool. This technology allows the expression of a gene of interest by eukaryotic cells in order to induce protective immune responses against the pathogen of interest. In this review, we discuss the strategies to choose the best DNA vaccine to be applied in the treatment and prevention of influenza. Specifically, we give an update of influenza DNA vaccines developments, all involved techniques, their main characteristics, applicability and technical features to obtain the best option against influenza infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available